Eton Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ETON Eton Pharmaceuticals Inc
LXRX Lexicon Pharmaceuticals Inc
BVS Bioventus Inc
TDS-U Telephone and Data Systems Inc
ELEV Elevation Oncology Inc
FRZA Forza X1 Inc
SIEN Sientra Inc
PMGM Priveterra Acquisition Corp
NVFY Nova LifeStyle Inc
GGIFF Garibaldi Resources Corp
Go

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Eton Pharmaceuticals, Inc. is a pharmaceutical company, which is developing, acquiring and commercializing products to address unmet needs in patients suffering from rare diseases. It has three commercial rare disease products, ALKINDI SPRINKLE for the treatment of adrenocortical insufficiency, Carglumic Acid for the treatment of hyperammonemia due to N-acetylglutamate synthase deficiency, and Betaine Anhydrous for the treatment of homocystinuria. It also has three additional product candidates in late-stage development. The Company is developing dehydrated alcohol injection, which has received Orphan Drug Designation for the treatment of methanol poisoning, ZENEO hydrocortisone autoinjector for the treatment of adrenal crisis, and ET-400. Its dehydrated alcohol injection product candidate is under review for the treatment of methanol poisoning. Its ZENEO hydrocortisone autoinjector product candidate is a needle-free autoinjector under development for the treatment of adrenal crisis.

Price
Delayed
$3.87
Day's Change
-0.02 (-0.51%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.93
Day's Low
3.85
Volume
(Light)

Today's volume of 4,031 shares is on pace to be much lighter than ETON's 10-day average volume of 46,800 shares.

4,031

Crown Castle Inc. Stock Falls Friday, Underperforms Market

4:43 pm ET March 17, 2023 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Crown Castle Inc. (CCI) slid 1.71% to $130.26 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.10% to 3,916.64 and Dow Jones Industrial Average falling 1.19% to 31,861.98. This was the stock's second consecutive day of losses. Crown Castle Inc. closed $69.71 short of its 52-week high ($199.97), which the company achieved on April 21st.

The stock underperformed when compared to some of its competitors Friday, as Verizon Communications Inc. (VZ) rose 0.57% to $36.79, AT&T Inc. (T) fell 1.41% to $18.13, and T-Mobile US Inc. (TMUS) rose 0.66% to $142.45. Trading volume (3.5 M) eclipsed its 50-day average volume of 2.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 17, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

	

(END) Dow Jones Newswires

March 17, 2023 16:43 ET (20:43 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.